Safety of Men With Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the NAAASP

Clare Oliver-Williams, Michael J Sweeting, Jo Jacomelli, Lisa Summers, Anne Stevenson, Tim Lees, Jonothan J Earnshaw, Clare Oliver-Williams, Michael J Sweeting, Jo Jacomelli, Lisa Summers, Anne Stevenson, Tim Lees, Jonothan J Earnshaw

Abstract

Background: Population screening for abdominal aortic aneurysm (AAA) has commenced in several countries, and has been shown to reduce AAA-related mortality by up to 50%. Most men who screen positive have an AAA <5.5 cm in diameter, the referral threshold for treatment, and are entered into an ultrasound surveillance program. This study aimed to determine the risk of ruptured AAA (rAAA) in men under surveillance.

Methods: Men in the National Health Service AAA Screening Programme who initially had a small (3-4.4 cm) or medium (4.5-5.4 cm) AAA were followed up. The screening program's database collected data on ultrasound AAA diameter measurements, dates of referral, and loss to follow-up. Local screening programs recorded adverse outcomes, including rAAA and death. Rupture and mortality rates were calculated by initial and final known AAA diameter.

Results: A total of 18 652 men were included (50 103 person-years of surveillance). Thirty-one men had rAAA during surveillance, of whom 29 died. Some 952 men died of other causes during surveillance, mainly cardiovascular complications (26.3%) and cancer (31.2%). The overall mortality rate was 1.96% per annum, similar for men with small and medium AAAs. The rAAA risk was 0.03% per annum (95% CI, 0.02%-0.05%) for men with small AAAs and 0.28% (0.17%-0.44%) for medium AAAs. The rAAA risk for men with AAAs just below the referral threshold (5.0-5.4 cm) was 0.40% (0.22%-0.73%).

Conclusions: The risk of rAAA under surveillance is <0.5% per annum, even just below the present referral threshold of 5.5 cm, and only 0.4% of men under surveillance are estimated to rupture before referral. It can be concluded that men with small and medium screen-detected AAAs are safe provided they are enrolled in an intensive surveillance program, and that there is no evidence that the current referral threshold of 5.5 cm should be changed.

Keywords: aortic aneurysm, abdominal; epidemiology; mass screening; men; ultrasonography.

Figures

Figure 1.
Figure 1.
Cumulative incidence of rupture during surveillance in the National Health Service Abdominal Aortic Aneurysm Screening Programme, 2009 to 2017, by initial diameter (3.0–4.4 cm/4.5–5.4 cm). Incidence of rupture was estimated with referral and mortality as competing risks.
Figure 2.
Figure 2.
Cumulative incidence of death during surveillance in the National Health Service Abdominal Aortic Aneurysm Screening Programme, 2009 to 2017, by initial diameter (3.0–4.4 cm/4.5–5.4 cm). Incidence of death was estimated with referral and mortality as competing risks.
Figure 3.
Figure 3.
Stacked cumulative incidence function plot for men under surveillance in the National Health Service Abdominal Aortic Aneurysm Screening Programme, 2009 to 2017.
Figure 4.
Figure 4.
Stacked cumulative incidence function plots for men under surveillance in the National Health Service Abdominal Aortic Aneurysm Screening Programme, 2009 to 2017, by initial diameter.A, 3.0 to 3.4 cm. B, 3.5 to 3.9 cm. C, 4.0 to 4.4 cm. D, 4.5 to 4.9 cm. E, 5.0 to 5.4 cm.

References

    1. Wanhainen A, Hultgren R, Linné A, Holst J, Gottsäter A, Langenskiöld M, Smidfelt K, Björck M, Svensjö S Swedish Aneurysm Screening Study Group (SASS) Outcome of the Swedish Nationwide Abdominal Aortic Aneurysm Screening Program. Circulation. 2016;134:1141–1148. doi: 10.1161/CIRCULATIONAHA.116.022305.
    1. Jacomelli J, Summers L, Stevenson A, Lees T, Earnshaw JJ. Impact of the first 5 years of a national abdominal aortic aneurysm screening programme. Br J Surg. 2016;103:1125–1131. doi: 10.1002/bjs.10173.
    1. Meecham L, Jacomelli J, Pherwani AD, Earnshaw J. Editor’s choice: self-referral to the NHS Abdominal Aortic Aneurysm Screening Programme. Eur J Vasc Endovasc Surg. 2016;52:317–321.
    1. Bown MJ, Sweeting MJ, Brown LC, Powell JT, Thompson SG RESCAN Collaborators. Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis. JAMA. 2013;309:806–813.
    1. Thompson SG, Ashton HA, Gao L, Buxton MJ, Scott RA Multicentre Aneurysm Screening Study (MASS) Group. Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg. 2012;99:1649–1656. doi: 10.1002/bjs.8897.
    1. Davis M, Harris M, Earnshaw JJ. Implementation of the National Health Service Abdominal Aortic Aneurysm Screening Program in England. J Vasc Surg. 2013;57:1440–1445. doi: 10.1016/j.jvs.2012.10.114.
    1. Powell JT, Brady AR, Brown LC, Fowkes FG, Greenhalgh RM, Ruckley CV, Thompson SG United Kingdom Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1445–1452.
    1. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, Ballard DJ, Messina LM, Gordon IL, Chute EP, Krupski WC, Busuttil SJ, Barone GW, Sparks S, Graham LM, Rapp JH, Makaroun MS, Moneta GL, Cambria RA, Makhoul RG, Eton D, Ansel HJ, Freischlag JA, Bandyk D Aneurysm Detection and Management Veterans Affairs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437–1444. doi: 10.1056/NEJMoa012573.
    1. Lindholt JS. Relatively high pulmonary and cardiovascular mortality rates in screening-detected aneurysmal patients without previous hospital admissions. Eur J Vasc Endovasc Surg. 2007;33:94–99. doi: 10.1016/j.ejvs.2006.06.007.
    1. Bath MF, Saratzis A, Saedon M, Sidloff D, Sayers R, Bown MJ UKAGS Investigators. Patients with small abdominal aortic aneurysm are at significant risk of cardiovascular events and this risk is not addressed sufficiently. Eur J Vasc Endovasc Surg. 2017;53:255–260. doi: 10.1016/j.ejvs.2016.10.013.
    1. Bahia SS, Vidal-Diez A, Seshasai SR, Shpitser I, Brownrigg JR, Patterson BO, Ray KK, Holt PJ, Thompson MM, Karthikesalingam A. Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm. Br J Surg. 2016;103:1626–1633. doi: 10.1002/bjs.10269.
    1. Vascular Society of Great Britain and Ireland. National Vascular Registry 2017 Annual Report. 2017. . Accessed February 15, 2019.
    1. Hartshorne TC, McCollum CN, Earnshaw JJ, Morris J, Nasim A. Ultrasound measurement of aortic diameter in a national screening programme. Eur J Vasc Endovasc Surg. 2011;42:195–199. doi: 10.1016/j.ejvs.2011.02.030.
    1. Office for National Statistics. National life tables: England and Wales. 2018. . Accessed February 15, 2019.
    1. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med. 1997;16:901–910.
    1. Duncan JL, Harrild KA, Iversen L, Lee AJ, Godden DJ. Long term outcomes in men screened for abdominal aortic aneurysm: prospective cohort study. BMJ. 2012;344:e2958. doi: 10.1136/bmj.e2958.
    1. Grant SW, Sperrin M, Carlson E, Chinai N, Ntais D, Hamilton M, Dunn G, Buchan I, Davies L, McCollum CN. Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation. Health Technol Assess. 2015;19:1–154, v. doi: 10.3310/hta19320.
    1. Cao P, De Rango P, Verzini F, Parlani G, Romano L, Cieri E CAESAR Trial Group. Comparison of surveillance versus aortic endografting for small aneurysm repair (CAESAR): results from a randomised trial. Eur J Vasc Endovasc Surg. 2011;41:13–25. doi: 10.1016/j.ejvs.2010.08.026.
    1. Forsythe RO, Newby DE. Cellular and molecular imaging of the arteries in the age of precision medicine. Br J Surg. 2018;105:311–312. doi: 10.1002/bjs.10841.
    1. Khosla S, Morris DR, Moxon JV, Walker PJ, Gasser TC, Golledge J. Meta-analysis of peak wall stress in ruptured, symptomatic and intact abdominal aortic aneurysms. Br J Surg. 2014;101:1350–1357; discussion 1357. doi: 10.1002/bjs.9578.
    1. Hinchliffe RJ, Earnshaw JJ. Vascular interventions in the elderly. Br J Surg. 2016;103:e16–e18. doi: 10.1002/bjs.10043.
    1. Karthikesalingam A, Vidal-Diez A, Holt PJ, Loftus IM, Schermerhorn ML, Soden PA, Landon BE, Thompson MM. Thresholds for abdominal aortic aneurysm repair in England and the United States. N Engl J Med. 2016;375:2051–2059. doi: 10.1056/NEJMoa1600931.
    1. Sweeting MJ, Masconi KL, Jones E, Ulug P, Glover MJ, Michaels JA, Bown MJ, Powell JT, Thompson SG. Analysis of clinical benefit, harms, and cost-effectiveness of screening women for abdominal aortic aneurysm. Lancet. 2018;392:487–495. doi: 10.1016/S0140-6736(18)31222-4.
    1. Jacomelli J, Summers L, Stevenson A, Lees T, Earnshaw JJ. Update on the prevention of death from ruptured abdominal aortic aneurysm. J Med Screen. 2017;24:166–168. doi: 10.1177/0969141316667409.
    1. Sidloff DA, Saratzis A, Sweeting MJ, Michaels J, Powell JT, Thompson SG, Bown MJ. Sex differences in mortality after abdominal aortic aneurysm repair in the UK. Br J Surg. 2017;104:1656–1664. doi: 10.1002/bjs.10600.
    1. Meecham L, Jacomelli J, Davis M, Pherwani P, Lees T, Warnshaw J, Earnshaw J. Outcomes in men from the NHS Abdominal Aortic Aneurysm Screening Programme with a large aneurysm referred for intervention. In press.
    1. Johansson M, Zahl PH, Siersma V, Jørgensen KJ, Marklund B, Brodersen J. Benefits and harms of screening men for abdominal aortic aneurysm in Sweden: a registry-based cohort study. Lancet. 2018;391:2441–2447. doi: 10.1016/S0140-6736(18)31031-6.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel